View Mobile Friendly Conference List »

Setting new standards in information exchange for the pharmaceutical and biotech industry

Blog

Building Blocks of IO Clinical Trials – Part 1


  • June 6, 2018

  • In this episode of Pharma Talk Radio, we feature Andy Lee, SVP and Head of Global Clinical Trial Operations and his team at Merck who spoke at IO360° in February 2018 on the Building Blocks of IO Clinical Trials. The Merck operations team detailed a day in the life of IO trial functions, how to work collaboratively and effectively, to advance the development of IO therapeutics. This is Part 1 of a 2 Part recording.

    Part 1 delved into:

    – A Patient Experience of an IO trial
    – Site Management
    – Clinical Oversight and Monitoring
    – Operational Aspects of PDL1 Stratification and Biomarkers

     
     
     
     
     
     
     
     
     
     
    Save the Date: The 5th annual Immuno-Oncology 360° program will take place February 6-8, 2019 in NYC. For more information visit: